addressing the disparity in ethnic variation in uk-based clinical trials for multiple myeloma
Published 1 year ago • 75 plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
4:18
the ethnic diversity in the presentation and outcome of wm and mgus in the united kingdom
-
2:31
uk practice: pomalidomide in patients resistant to lenalidomide
-
1:53
the future of multiple myeloma treatment
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
3:37
smoldering myeloma: state of the art
-
2:59
optimismm study update
-
3:22
chromothripsis and chromoplexy in myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma
-
1:37
mrd in myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:11
future myeloma treatment strategies
-
2:11
overview and rationale for practical workshops at the 2016 european multiple myeloma academy (emma)
-
2:20
overcoming lack of diversity in cancer clinical trials
-
0:40
the impact of an evolving first-line setting on subsequent treatment lines in multiple myeloma
-
1:59
myeloma: bites & cars
-
1:24
highlights from the 2016 european multiple myeloma academy (emma) and overview of emma 2017
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
5:38
personalized medicine in multiple myeloma